{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:41Z","timestamp":1707524741562},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,7]]},"DOI":"10.7759\/cureus.28898","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T18:04:13Z","timestamp":1662573853000},"source":"Crossref","is-referenced-by-count":0,"title":["Procalcitonin Testing With Secondary Coinfection in Patients With COVID-19"],"prefix":"10.7759","author":[{"given":"Rashid","family":"Nadeem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind M","family":"Aljaghber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"Elgohary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aju","family":"Rafeeq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishma","family":"Aijazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIba A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad R","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binu","family":"Velappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohanned H","family":"Aljanahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moatz Galal","family":"Mohamed Ali Elzeiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","volume":"323","author":"Grasselli G","year":"2020","unstructured":"Grasselli G, Zangrillo A, Zanella A, et al.. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020, 323:1574-81. 10.1001\/jama.2020.5394","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1825365","article-title":"Clinical features predicting mortality risk in older patients with COVID-19","volume":"36","author":"Zhou J","year":"2020","unstructured":"Zhou J, Huang L, Chen J, et al.. Clinical features predicting mortality risk in older patients with COVID-19. Curr Med Res Opin. 2020, 36:1753-9. 10.1080\/03007995.2020.1825365","journal-title":"Curr Med Res Opin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","volume":"81","author":"Lansbury L","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020, 81:266-75. 10.1016\/j.jinf.2020.05.046","journal-title":"J Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-2123-y","article-title":"Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea","volume":"37","author":"Antonelli M","year":"2011","unstructured":"Antonelli M, Azoulay E, Bonten M, et al.. Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea. Intensive Care Med. 2011, 37:196-213. 10.1007\/s00134-010-2123-y","journal-title":"Intensive Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012560","article-title":"SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?","volume":"12","author":"Bengoechea JA","year":"2020","unstructured":"Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?. EMBO Mol Med. 2020, 12:e12560. 10.15252\/emmm.202012560","journal-title":"EMBO Mol Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York City","volume":"382","author":"Goyal P","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC, et al.. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020, 382:2372-4. 10.1056\/NEJMc2010419","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06323-9","article-title":"Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study","volume":"47","author":"Rouz\u00e9 A","year":"2021","unstructured":"Rouz\u00e9 A, Martin-Loeches I, Povoa P, et al.. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med. 2021, 47:188-98. 10.1007\/s00134-020-06323-9","journal-title":"Intensive Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2014.34.4.263","article-title":"Update on procalcitonin measurements","volume":"34","author":"Meisner M","year":"2014","unstructured":"Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014, 34:263-73. 10.3343\/alm.2014.34.4.263","journal-title":"Ann Lab Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262342","article-title":"Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: a case-control study","volume":"17","author":"Atallah NJ","year":"2022","unstructured":"Atallah NJ, Warren HM, Roberts MB, et al.. Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: a case-control study. PLoS One. 2022, 17:e0262342. 10.1371\/journal.pone.0262342","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/ajem.2002.33005","article-title":"Diagnostic value of procalcitonin levels as an early indicator of sepsis","volume":"20","author":"Guven H","year":"2002","unstructured":"Guven H, Altintop L, Baydin A, et al.. Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med. 2002, 20:202-6. 10.1053\/ajem.2002.33005","journal-title":"Am J Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106051","article-title":"Procalcitonin levels in COVID-19 patients","volume":"56","author":"Hu R","year":"2020","unstructured":"Hu R, Han C, Pei S, Yin M, Chen X. Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agents. 2020, 56:106051. 10.1016\/j.ijantimicag.2020.106051","journal-title":"Int J Antimicrob Agents"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2021.01.001","article-title":"Immune reactivity during COVID-19: implications for treatment","volume":"231","author":"Napoli C","year":"2021","unstructured":"Napoli C, Benincasa G, Criscuolo C, Faenza M, Liberato C, Rusciano M. Immune reactivity during COVID-19: implications for treatment. Immunol Lett. 2021, 231:28-34. 10.1016\/j.imlet.2021.01.001","journal-title":"Immunol Lett"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2067","article-title":"Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis","volume":"8","author":"Soni NJ","year":"2013","unstructured":"Soni NJ, Samson DJ, Galaydick JL, Vats V, Huang ES, Aronson N, Pitrak DL. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis. J Hosp Med. 2013, 8:530-40. 10.1002\/jhm.2067","journal-title":"J Hosp Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00053209","article-title":"Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study","volume":"34","author":"Stolz D","year":"2009","unstructured":"Stolz D, Smyrnios N, Eggimann P, et al.. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J. 2009, 34:1364-75. 10.1183\/09031936.00053209","journal-title":"Eur Respir J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2021.01.006","article-title":"Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study","volume":"110","author":"Williams EJ","year":"2021","unstructured":"Williams EJ, Mair L, de Silva TI, et al.. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study. J Hosp Infect. 2021, 110:103-7. 10.1016\/j.jhin.2021.01.006","journal-title":"J Hosp Infect"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10091119","article-title":"Procalcitonin to guide antibacterial prescribing in patients hospitalised with COVID-19","volume":"10","author":"Hughes S","year":"2021","unstructured":"Hughes S, Mughal N, Moore LS. Procalcitonin to guide antibacterial prescribing in patients hospitalised with COVID-19. Antibiotics (Basel). 2021, 10:1119. 10.3390\/antibiotics10091119","journal-title":"Antibiotics (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.03.044","article-title":"Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19","volume":"119","author":"Jackson I","year":"2022","unstructured":"Jackson I, Jaradeh H, Aurit S, Aldamen A, Narechania S, Destache C, Velagapudi M. Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19. Int J Infect Dis. 2022, 119:47-52. 10.1016\/j.ijid.2022.03.044","journal-title":"Int J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1159\/000516591","article-title":"Clinical profile of mortality and treatment profile of survival in patients with COVID-19 pneumonia admitted to Dubai Hospital","volume":"4","author":"Nadeem R","year":"2021","unstructured":"Nadeem R, Aijazi I, Elhoufi A et al.. Clinical profile of mortality and treatment profile of survival in patients with COVID-19 pneumonia admitted to Dubai Hospital. Dubai Med J. 2021, 4:170-6.","journal-title":"Dubai Med J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00686-4","article-title":"COVID-19-associated invasive pulmonary aspergillosis","volume":"10","author":"Rutsaert L","year":"2020","unstructured":"Rutsaert L, Steinfort N, Van Hunsel T, et al.. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020, 10:71. 10.1186\/s13613-020-00686-4","journal-title":"Ann Intensive Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-2018LE","article-title":"Detection of invasive pulmonary Aspergillosis in COVID-19 with nondirected BAL","volume":"202","author":"Van Biesen S","year":"2020","unstructured":"Van Biesen S, Kwa D, Bosman RJ, Juffermans NP. Detection of invasive pulmonary Aspergillosis in COVID-19 with nondirected BAL. Am J Respir Crit Care Med. 2020, 202:1171-3. 10.1164\/rccm.202005-2018LE","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/107219-procalcitonin-testing-with-secondary-coinfection-in-patients-with-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:39Z","timestamp":1707507999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/107219-procalcitonin-testing-with-secondary-coinfection-in-patients-with-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.28898","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,7]]}}}